A study of left atrial maze-like catheter linear ablation in persistent atrial fibrillation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052182

Enrollment

Unknown

Registered

2021-10-21

Start date

2021-11-01

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Experimental group:linear ablation

control group:No

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with persistent atrial fibrillation undergoing catheter ablation for the first time.

Exclusion criteria

Exclusion criteria: 1. Complicated with organic heart disease such as cardiomyopathy, coronary heart disease, rheumatic heart disease; 2. Electrolyte disorders; 3. Hyperthyroidism; 4. Congenital heart disease; 5. Moderate-severe valvular disease; 6. Have received cardiac surgery in the past; 7. The inner diameter of the left atrium is greater than 55mm; 8. The duration of atrial fibrillation is greater than 5 years.

Design outcomes

Primary

Measure	Time frame
recurrence;	—

Countries

China

Contacts

Public ContactYin Xiaomeng

The First Affiliated Hospital of Dalian Medical University

yin_xiaomeng@126.com+86 411 83635863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026